author_facet Bhat, Narayan R.
Bhat, Narayan R.
author Bhat, Narayan R.
spellingShingle Bhat, Narayan R.
Journal of Neurochemistry
Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
Cellular and Molecular Neuroscience
Biochemistry
author_sort bhat, narayan r.
spelling Bhat, Narayan R. 0022-3042 1471-4159 Wiley Cellular and Molecular Neuroscience Biochemistry http://dx.doi.org/10.1111/j.1471-4159.2010.06978.x <jats:sec><jats:label /><jats:p> <jats:italic>J. Neurochem.</jats:italic> (2010) <jats:bold>115</jats:bold>, 551–562.</jats:p></jats:sec><jats:sec><jats:title>Abstract</jats:title><jats:p>There is increasing evidence that the incidence of Alzheimer’s disease (AD) is significantly influenced by cardiovascular risk factors in association with a cluster of metabolic diseases including diabetes and atherosclerosis. The shared risk is also reflected in the dietary and lifestyle links to both metabolic disorders and AD‐type cognitive dysfunction. Recent studies with genetic and diet‐induced animal models have begun to illuminate convergent mechanisms and mediators between these two categories of disease conditions with distinct tissue‐specific pathologies. Although it is clear that peripheral inflammation and insulin resistance are central to the pathogenesis of the disorders of metabolic syndrome, it seems that the same mechanisms are also in play across the blood–brain barrier that lead to AD‐like molecular and cognitive changes. This review highlights these convergent mechanisms and discusses the role of cerebrovascular dysfunction as a conduit to brain emergence of these pathogenic processes that might also represent future therapeutic targets in AD in common with metabolic disorders.</jats:p></jats:sec> Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators Journal of Neurochemistry
doi_str_mv 10.1111/j.1471-4159.2010.06978.x
facet_avail Online
Free
finc_class_facet Biologie
Psychologie
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzEtNDE1OS4yMDEwLjA2OTc4Lng
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzEtNDE1OS4yMDEwLjA2OTc4Lng
institution DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
imprint Wiley, 2010
imprint_str_mv Wiley, 2010
issn 0022-3042
1471-4159
issn_str_mv 0022-3042
1471-4159
language English
mega_collection Wiley (CrossRef)
match_str bhat2010linkingcardiometabolicdisorderstosporadicalzheimersdiseaseaperspectiveonpotentialmechanismsandmediators
publishDateSort 2010
publisher Wiley
recordtype ai
record_format ai
series Journal of Neurochemistry
source_id 49
title Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_unstemmed Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_full Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_fullStr Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_full_unstemmed Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_short Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_sort linking cardiometabolic disorders to sporadic alzheimer’s disease: a perspective on potential mechanisms and mediators
topic Cellular and Molecular Neuroscience
Biochemistry
url http://dx.doi.org/10.1111/j.1471-4159.2010.06978.x
publishDate 2010
physical 551-562
description <jats:sec><jats:label /><jats:p> <jats:italic>J. Neurochem.</jats:italic> (2010) <jats:bold>115</jats:bold>, 551–562.</jats:p></jats:sec><jats:sec><jats:title>Abstract</jats:title><jats:p>There is increasing evidence that the incidence of Alzheimer’s disease (AD) is significantly influenced by cardiovascular risk factors in association with a cluster of metabolic diseases including diabetes and atherosclerosis. The shared risk is also reflected in the dietary and lifestyle links to both metabolic disorders and AD‐type cognitive dysfunction. Recent studies with genetic and diet‐induced animal models have begun to illuminate convergent mechanisms and mediators between these two categories of disease conditions with distinct tissue‐specific pathologies. Although it is clear that peripheral inflammation and insulin resistance are central to the pathogenesis of the disorders of metabolic syndrome, it seems that the same mechanisms are also in play across the blood–brain barrier that lead to AD‐like molecular and cognitive changes. This review highlights these convergent mechanisms and discusses the role of cerebrovascular dysfunction as a conduit to brain emergence of these pathogenic processes that might also represent future therapeutic targets in AD in common with metabolic disorders.</jats:p></jats:sec>
container_issue 3
container_start_page 551
container_title Journal of Neurochemistry
container_volume 115
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792346248445952010
geogr_code not assigned
last_indexed 2024-03-01T17:36:22.129Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Linking+cardiometabolic+disorders+to+sporadic+Alzheimer%E2%80%99s+disease%3A+a+perspective+on+potential+mechanisms+and+mediators&rft.date=2010-11-01&genre=article&issn=1471-4159&volume=115&issue=3&spage=551&epage=562&pages=551-562&jtitle=Journal+of+Neurochemistry&atitle=Linking+cardiometabolic+disorders+to+sporadic+Alzheimer%E2%80%99s+disease%3A+a+perspective+on+potential+mechanisms+and+mediators&aulast=Bhat&aufirst=Narayan+R.&rft_id=info%3Adoi%2F10.1111%2Fj.1471-4159.2010.06978.x&rft.language%5B0%5D=eng
SOLR
_version_ 1792346248445952010
author Bhat, Narayan R.
author_facet Bhat, Narayan R., Bhat, Narayan R.
author_sort bhat, narayan r.
container_issue 3
container_start_page 551
container_title Journal of Neurochemistry
container_volume 115
description <jats:sec><jats:label /><jats:p> <jats:italic>J. Neurochem.</jats:italic> (2010) <jats:bold>115</jats:bold>, 551–562.</jats:p></jats:sec><jats:sec><jats:title>Abstract</jats:title><jats:p>There is increasing evidence that the incidence of Alzheimer’s disease (AD) is significantly influenced by cardiovascular risk factors in association with a cluster of metabolic diseases including diabetes and atherosclerosis. The shared risk is also reflected in the dietary and lifestyle links to both metabolic disorders and AD‐type cognitive dysfunction. Recent studies with genetic and diet‐induced animal models have begun to illuminate convergent mechanisms and mediators between these two categories of disease conditions with distinct tissue‐specific pathologies. Although it is clear that peripheral inflammation and insulin resistance are central to the pathogenesis of the disorders of metabolic syndrome, it seems that the same mechanisms are also in play across the blood–brain barrier that lead to AD‐like molecular and cognitive changes. This review highlights these convergent mechanisms and discusses the role of cerebrovascular dysfunction as a conduit to brain emergence of these pathogenic processes that might also represent future therapeutic targets in AD in common with metabolic disorders.</jats:p></jats:sec>
doi_str_mv 10.1111/j.1471-4159.2010.06978.x
facet_avail Online, Free
finc_class_facet Biologie, Psychologie, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzEtNDE1OS4yMDEwLjA2OTc4Lng
imprint Wiley, 2010
imprint_str_mv Wiley, 2010
institution DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4
issn 0022-3042, 1471-4159
issn_str_mv 0022-3042, 1471-4159
language English
last_indexed 2024-03-01T17:36:22.129Z
match_str bhat2010linkingcardiometabolicdisorderstosporadicalzheimersdiseaseaperspectiveonpotentialmechanismsandmediators
mega_collection Wiley (CrossRef)
physical 551-562
publishDate 2010
publishDateSort 2010
publisher Wiley
record_format ai
recordtype ai
series Journal of Neurochemistry
source_id 49
spelling Bhat, Narayan R. 0022-3042 1471-4159 Wiley Cellular and Molecular Neuroscience Biochemistry http://dx.doi.org/10.1111/j.1471-4159.2010.06978.x <jats:sec><jats:label /><jats:p> <jats:italic>J. Neurochem.</jats:italic> (2010) <jats:bold>115</jats:bold>, 551–562.</jats:p></jats:sec><jats:sec><jats:title>Abstract</jats:title><jats:p>There is increasing evidence that the incidence of Alzheimer’s disease (AD) is significantly influenced by cardiovascular risk factors in association with a cluster of metabolic diseases including diabetes and atherosclerosis. The shared risk is also reflected in the dietary and lifestyle links to both metabolic disorders and AD‐type cognitive dysfunction. Recent studies with genetic and diet‐induced animal models have begun to illuminate convergent mechanisms and mediators between these two categories of disease conditions with distinct tissue‐specific pathologies. Although it is clear that peripheral inflammation and insulin resistance are central to the pathogenesis of the disorders of metabolic syndrome, it seems that the same mechanisms are also in play across the blood–brain barrier that lead to AD‐like molecular and cognitive changes. This review highlights these convergent mechanisms and discusses the role of cerebrovascular dysfunction as a conduit to brain emergence of these pathogenic processes that might also represent future therapeutic targets in AD in common with metabolic disorders.</jats:p></jats:sec> Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators Journal of Neurochemistry
spellingShingle Bhat, Narayan R., Journal of Neurochemistry, Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators, Cellular and Molecular Neuroscience, Biochemistry
title Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_full Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_fullStr Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_full_unstemmed Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_short Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
title_sort linking cardiometabolic disorders to sporadic alzheimer’s disease: a perspective on potential mechanisms and mediators
title_unstemmed Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators
topic Cellular and Molecular Neuroscience, Biochemistry
url http://dx.doi.org/10.1111/j.1471-4159.2010.06978.x